Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.46 |
| ▸ | DRD3 | P35462 | 2/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | EBP | Q15125 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30346054 | 1.00 | DRD2 (0.46) | DRD2DRD3CHRM2HTR1AADRA2A | |
| Iodide SCHEMBL29490760 | 0.98 | DRD2 (0.45) | DRD2DRD3CHRM2HTR1AADRA2A | |
| SCHEMBL10760089 | 0.85 | CHRM2 (0.38) | DRD2DRD3CHRM2HTR1AADRA2A | |
| SCHEMBL6902153 | 0.82 | HTR2A (0.35) | DRD2DRD3CHRM2HTR1AADRA2A | |
| SCHEMBL29984959 | 0.82 | CHRM2 (0.33) | DRD2DRD3CHRM2HTR1AADRA2A | |
| SCHEMBL9008261 | 0.82 | KMT2A (0.42) | DRD2DRD3CHRM2HTR1AADRA2A | |
| SCHEMBL30753563 | 0.82 | KMT2A (0.42) | DRD2DRD3CHRM2HTR1AADRA2A | |
| SCHEMBL29128835 | 0.79 | MAPK1 (0.33) | DRD2DRD3CHRM2HTR1AADRA2A | |
| SCHEMBL16836340 | 0.79 | DRD2 (0.37) | DRD2DRD3CHRM2HTR1AADRA2A | |
| SCHEMBL28881123 | 0.79 | POLB (0.36) | DRD2DRD3CHRM2HTR1AADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12274745-B2 | Conjugate of CAPRIN-1 antibody linked to immune activator for cancer treatment | TORAY INDUSTRIES, INC. (JP) | 2025-04-15 | — | — | US | claimed |
| CN-115461073-A | In vitro methods and compositions for enhancing dendritic cell and T cell activation and for inducing Th-1 immune responses | 西北生物治疗药物公司 | 2022-12-09 | — | — | CN | claimed |
| EP-3937939-A1 | IMMUNE MODULATORY COMPOSITIONS AND METHODS FOR TREATING CANCERS | Birdie Biopharmaceuticals Inc. (KY) | 2022-01-19 | — | — | EP | claimed |
| EP-3763742-A1 | ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS | Birdie Biopharmaceuticals Inc. (KY) | 2021-01-13 | — | — | EP | claimed |
| WO-2020190690-A1 | IMMUNE MODULATORY COMPOSITIONS AND METHODS FOR TREATING CANCERS | BIRDIE BIOPHARMACEUTICALS, INC. (KY) | 2020-09-24 | — | — | WO | claimed |
| CN-107074959-A | Anti- PD L1 conjugates for treating tumour | 博笛生物科技有限公司 | 2017-08-18 | — | — | CN | claimed |
| CN-107074958-A | Anti- PD L1 for treating tumour are combined | 博笛生物科技有限公司 | 2017-08-18 | — | — | CN | claimed |
| CN-106943598-A | anti-HER 2 combination for treating tumors | 博笛生物科技（北京）有限公司 | 2017-07-14 | — | — | CN | claimed |
| CN-102600461-B | Give outer body ripe dendritic cells treatment tumour | 西北生物治疗药物公司 | 2017-07-14 | — | — | CN | claimed |
| CN-106943596-A | anti-CD 20 combination for use in the treatment of tumors | 博笛生物科技（北京）有限公司 | 2017-07-14 | — | — | CN | claimed |
| CN-1604792-A | Agents for enhancing the immune response | BECTON DICKINSON CO (US) | 2005-04-06 | — | — | CN | claimed |
| CN-1602216-A | Microprojection array immunization patch and method | ALZA CORP (US) | 2005-03-30 | — | — | CN | claimed |
| CN-1555264-A | Formulations for treatment of mucosal associated conditions with an immune response modifier | 3M | 2004-12-15 | — | — | CN | claimed |
| CN-1523987-A | Immune response modifiers for the treatment of periodontal disease | 3M创新有限公司 | 2004-08-25 | — | — | CN | claimed |
| CN-1455671-A | Methods for delaying recurrence of herpes virus symptoms | 3M INNOVATIVE PROPERTIES CO (US) | 2003-11-12 | — | — | CN | claimed |
| CN-1437463-A | System and method for treating a mucosal surface | 3M INNOVATIVE PROPERTIES CO (US) | 2003-08-20 | — | — | CN | claimed |
| CN-1114400-C | Biocompatible compounds for pharmaceutical drug delivery systems | MINNESOTA MINING & MFG (US) | 2003-07-16 | — | — | CN | claimed |
| CN-1246790-A | Biocompatible compounds for pharmaceutical drug delivery systems | MINNESOTA MINING & MFG (US) | 2000-03-08 | — | — | CN | claimed |
| EP-0942724-A2 | GEL FORMULATIONS FOR TOPICAL DRUG DELIVERY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-09-22 | — | — | EP | claimed |
| WO-1998024436-A2 | GEL FORMULATIONS FOR TOPICAL DRUG DELIVERY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-06-11 | — | — | WO | claimed |